Xeris Pharmaceuticals's total assets for Q3 2025 were $370.19M, an increase of 10.61% from the previous quarter. XERS total liabilities were $371.05M for the fiscal quarter, a 4.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.